Your browser doesn't support javascript.
loading
Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection.
Cubas, Rafael; van Grevenynghe, Julien; Wills, Saintedym; Kardava, Lela; Santich, Brian H; Buckner, Clarisa M; Muir, Roshell; Tardif, Virginie; Nichols, Carmen; Procopio, Francesco; He, Zhong; Metcalf, Talibah; Ghneim, Khader; Locci, Michela; Ancuta, Petronella; Routy, Jean-Pierre; Trautmann, Lydie; Li, Yuxing; McDermott, Adrian B; Koup, Rick A; Petrovas, Constantinos; Migueles, Steven A; Connors, Mark; Tomaras, Georgia D; Moir, Susan; Crotty, Shane; Haddad, Elias K.
Affiliation
  • Cubas R; Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL 34987;
  • van Grevenynghe J; Institut National de la Recherche Scientifique, Institut Armand-Frappier, Laval H7V 1B7, Quebec, Canada;
  • Wills S; Department of Immunology and the Duke Human Vaccine Institute, Duke University, Durham, NC 27710;
  • Kardava L; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Santich BH; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Buckner CM; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Muir R; Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL 34987;
  • Tardif V; Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL 34987;
  • Nichols C; Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL 34987;
  • Procopio F; Service d'Immunologie et Allergie, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland;
  • He Z; Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL 34987;
  • Metcalf T; Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL 34987;
  • Ghneim K; Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL 34987;
  • Locci M; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;
  • Ancuta P; Department of Medicine, University of Montreal, Montreal, Quebec H3C 3J7, Canada; Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, University of Montreal, Montreal, Quebec H3C 3J7, Canada;
  • Routy JP; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec H3H 2R9, Canada; Research Institute, McGill University Health Centre, Montreal, Quebec H3H 2R9, Canada; Division of Hematology, McGill University Health Centre, Montreal, Quebec H3H 2R9, Canada;
  • Trautmann L; Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL 34987;
  • Li Y; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037;
  • McDermott AB; Immunology Laboratory, Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Koup RA; Immunology Laboratory, Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Petrovas C; Immunology Laboratory, Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Migueles SA; HIV-Specific Immunity Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Connors M; HIV-Specific Immunity Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Tomaras GD; Department of Immunology and the Duke Human Vaccine Institute, Duke University, Durham, NC 27710;
  • Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
  • Crotty S; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093; and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037.
  • Haddad EK; Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL 34987; elias.elhaddad@drexelmed.edu.
J Immunol ; 195(12): 5625-36, 2015 Dec 15.
Article in En | MEDLINE | ID: mdl-26546609
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: B-Lymphocytes / HIV Infections / HIV / Interleukin-2 / T-Lymphocytes, Helper-Inducer Limits: Adult / Humans / Middle aged Language: En Journal: J Immunol Year: 2015 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: B-Lymphocytes / HIV Infections / HIV / Interleukin-2 / T-Lymphocytes, Helper-Inducer Limits: Adult / Humans / Middle aged Language: En Journal: J Immunol Year: 2015 Type: Article